MasTec (NYSE: MTZ) director now holds 30,880 shares
Rhea-AI Filing Summary
MASTEC INC (MTZ) reported that director Campbell C. Robert received a grant or award of 139 shares of Common Stock on 2026-08-14. The shares were acquired at a stated price of $0.00 per share as a non-derivative equity award, bringing the director’s directly held stake to 30,880 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 139 shares
Net Buy
1 txn
Insider
Campbell C Robert
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 139 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 30,880 shares (Direct)
Key Figures
Shares granted: 139 shares
Transaction price per share: $0.00
Shares owned after transaction: 30,880 shares
3 metrics
Shares granted
139 shares
Non-derivative Common Stock award on 2026-08-14
Transaction price per share
$0.00
Stated price for the 139-share Common Stock award
Shares owned after transaction
30,880 shares
Director’s directly held MTZ Common Stock following the grant
Key Terms
Form 4, non-derivative, grant/award acquisition
3 terms
Form 4 regulatory
"reported on Form 4 by a director as an insider transaction"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
non-derivative financial
"The shares were acquired as a non-derivative equity award"
grant/award acquisition financial
"described as a grant/award acquisition of Common Stock"
FAQ
What insider transaction did MTZ disclose for Campbell C. Robert?
MTZ disclosed that director Campbell C. Robert received a grant or award of 139 Common Stock shares on 2026-08-14. This is a non-derivative equity award reported on Form 4, increasing his directly held stake in MASTEC INC.
Was the MTZ Form 4 transaction a purchase or a grant?
The MTZ Form 4 transaction was a grant or award acquisition, coded “A” for an award or other acquisition, not an open-market purchase. The filing describes it as a non-derivative equity award of 139 Common Stock shares at a stated price of $0.00.
Does the MTZ Form 4 indicate use of a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan. Combined with the award nature of the transaction, this indicates the 139-share grant was a compensation-related equity award rather than trading under a pre-arranged 10b5-1 plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.